Is 5-Amino-1MQ safe?
Limited EvidenceSide effects, risks, and safety considerations based on available research.
Research status
5-Amino-1MQ has very limited human safety data. Most information comes from animal studies, in vitro research, or anecdotal reports. This means the true risk profile in humans is largely unknown.
Known concerns & side effects
- ⚠no published human clinical trials — all evidence is preclinical
- ⚠not FDA-approved for any indication
- ⚠technically a small molecule, not a peptide — regulatory pathway and safety profile differ
- ⚠long-term effects of NNMT inhibition in humans are completely unknown
- ⚠NAD+ and SAM are involved in hundreds of biological processes — chronic NNMT inhibition could have widespread unintended effects
- ⚠sourcing from research chemical suppliers carries significant purity and contamination risks
Use caution with
Relevant safety research
NNMT inhibition with 5-amino-1MQ reduces diet-induced obesity in mice
Finding: Treatment with 5-Amino-1MQ for 11 days reduced body weight by ~7% in diet-induced obese mice without affecting food intake. Fat mass decreased while lean mass was preserved. Adipocyte size was significantly reduced.
Limitation: Mouse study only. Short treatment duration. No assessment of long-term safety or effects on NNMT's other biological roles.
See all 3 studies on the full 5-Amino-1MQ profile.
Frequently asked questions
Is 5-Amino-1MQ actually a peptide?
No. 5-Amino-1MQ is a small molecule quinolinium compound, not a peptide. It is widely marketed and sold alongside peptides because it targets metabolic pathways popular in the peptide community and is sold by the same suppliers. We include it because it is commonly searched for in the peptide context.
How does 5-Amino-1MQ relate to NAD+ supplements like NMN?
Both aim to increase cellular NAD+ levels but through different mechanisms. NMN provides a direct precursor for NAD+ synthesis. 5-Amino-1MQ blocks NNMT, an enzyme that degrades NAD+ precursors. In theory, they could be complementary, but combined use has not been studied in humans.
Why is NNMT a target for obesity?
NNMT is significantly overexpressed in the fat tissue of obese individuals. It depletes SAM and NAD+, which are critical for cellular energy metabolism. In mouse models, blocking NNMT reduced fat cell size, increased energy expenditure, and prevented diet-induced obesity. However, NNMT also plays roles in drug metabolism and other processes, so inhibiting it could have unintended consequences.
Full 5-Amino-1MQ Profile
Evidence, timeline, products & more
Take the Peptide Quiz
Get personalized recommendations
Last updated: 2026-04-26
Medical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.